Literature DB >> 19112036

Analysis of lymphocyte subgroups in Crimean-Congo hemorrhagic fever.

Esragül Akinci1, Mesude Yilmaz, Hürrem Bodur, Pinar Ongürü, Fatma Nurhayat Bayazit, Ayşe Erbay, Gülsüm Ozet.   

Abstract

OBJECTIVES: This study examined the association between lymphocyte subgroups and mortality in patients with Crimean-Congo hemorrhagic fever (CCHF) in Turkey.
METHODS: During the spring and summer of 2007, peripheral blood was collected from hospitalized patients with suspected CCHF. Lymphocyte subgroups were characterized by fluorescence-activated cell sorting. CCHF cases were confirmed by detecting viral RNA by PCR and/or IgM antibodies by ELISA. Lymphocyte subgroups were compared between fatal and non-fatal cases. The correlation between lymphocyte subgroups and viral loads was also investigated.
RESULTS: Seventy-seven confirmed cases of CCHF were included in this study (five cases were fatal (6.5 %)). No differences in lymphocyte subgroups were found between fatal and non-fatal cases, except for significantly higher CD3+CD8+ T cells in the fatal cases (p=0.017). A positive correlation between viral load and CD3+CD8+ T cells was also detected (p=0.044). There was no correlation between other lymphocyte subgroups and viral load.
CONCLUSIONS: Higher levels of CD3+CD8+ T lymphocytes were detected in fatal compared to non-fatal CCHF cases. Despite this cytotoxic immune activation, a fatal outcome could not be prevented. We hypothesize that high viral load and other factors may influence this outcome, although more studies are required to explain the pathogenesis of CCHF.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19112036     DOI: 10.1016/j.ijid.2008.08.027

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  12 in total

1.  Exploring Crimean-Congo Hemorrhagic Fever Virus-Induced Hepatic Injury Using Antibody-Mediated Type I Interferon Blockade in Mice.

Authors:  Michael E Lindquist; Xiankun Zeng; Louis A Altamura; Sharon P Daye; Korey L Delp; Candace Blancett; Kayla M Coffin; Jeffrey W Koehler; Susan Coyne; Charles J Shoemaker; Aura R Garrison; Joseph W Golden
Journal:  J Virol       Date:  2018-10-12       Impact factor: 5.103

2.  Crimean-Congo Hemorrhagic Fever Mouse Model Recapitulating Human Convalescence.

Authors:  David W Hawman; Kimberly Meade-White; Elaine Haddock; Rumi Habib; Dana Scott; Tina Thomas; Rebecca Rosenke; Heinz Feldmann
Journal:  J Virol       Date:  2019-08-28       Impact factor: 5.103

3.  Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model.

Authors:  Dennis A Bente; Judie B Alimonti; Wun-Ju Shieh; Gaëlle Camus; Ute Ströher; Sherif Zaki; Steven M Jones
Journal:  J Virol       Date:  2010-08-25       Impact factor: 5.103

Review 4.  Immunobiology of Crimean-Congo hemorrhagic fever.

Authors:  Sergio E Rodriguez; David W Hawman; Teresa E Sorvillo; T Justin O'Neal; Brian H Bird; Luis L Rodriguez; Éric Bergeron; Stuart T Nichol; Joel M Montgomery; Christina F Spiropoulou; Jessica R Spengler
Journal:  Antiviral Res       Date:  2022-01-11       Impact factor: 10.103

Review 5.  Development of vaccines against Crimean-Congo haemorrhagic fever virus.

Authors:  Stuart D Dowall; Miles W Carroll; Roger Hewson
Journal:  Vaccine       Date:  2017-07-04       Impact factor: 3.641

Review 6.  Crimean-Congo Hemorrhagic Fever: Tick-Host-Virus Interactions.

Authors:  Anna Papa; Katerina Tsergouli; Katerina Tsioka; Ali Mirazimi
Journal:  Front Cell Infect Microbiol       Date:  2017-05-26       Impact factor: 5.293

Review 7.  Recent advances in understanding Crimean-Congo hemorrhagic fever virus.

Authors:  David W Hawman; Heinz Feldmann
Journal:  F1000Res       Date:  2018-10-29

8.  A novel vaccine against Crimean-Congo Haemorrhagic Fever protects 100% of animals against lethal challenge in a mouse model.

Authors:  Karen R Buttigieg; Stuart D Dowall; Stephen Findlay-Wilson; Aleksandra Miloszewska; Emma Rayner; Roger Hewson; Miles W Carroll
Journal:  PLoS One       Date:  2014-03-12       Impact factor: 3.240

Review 9.  Natural killer cell responses to emerging viruses of zoonotic origin.

Authors:  Carlos Diaz-Salazar; Joseph C Sun
Journal:  Curr Opin Virol       Date:  2020-08-09       Impact factor: 7.090

Review 10.  The Utility of Human Immune System Mice for High-Containment Viral Hemorrhagic Fever Research.

Authors:  David M Wozniak; Kerry J Lavender; Joseph Prescott; Jessica R Spengler
Journal:  Vaccines (Basel)       Date:  2020-02-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.